Clinical Trial Update: Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+ [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lenalidomide with subcutaneous rituximab plus miniCHOP in elderly patients with Diffuse Large B-Cell Lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Rituximab (rituximab)
• miniCHOP

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Diffuse Large B Cell Lymphoma | Phase 3 | Status: COMPLETED